TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/12/23 17:26 | 5/11/23 | AMPE | Ampio Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stevens David R | WA | D | P.m | 21 | 0.2187 | 0 | 95 | 999% | 104 | D | |||||||||||||||
6/10/11 16:49 | 6/9/11 | PARD | Poniard Pharmaceuticals, Inc. | WA | Health | Drug | Pharmaceutical Preparations | Stevens David R | WA | D | M.d | 0 | 0.00 | 0 | 36 | 182 | 56 | D | |||||||||||||||
1/13/09 16:25 | 1/9/09 | PARD | Poniard Pharmaceuticals, Inc. | WA | Health | Drug | Pharmaceutical Preparations | Stevens David R | WA | D | P | 22 | 3.44 | 0 | 6 | 48 | 20 | ||||||||||||||||
1/16/08 15:31 | 1/15/08 | PARD | Poniard Pharmaceuticals, Inc. | WA | Health | Diagn | In Vitro & In Vivo Diagnostic | Stevens David R | WA | D | P | 40 | 5.25 | 0 | 8 | 132 | 13 | D | |||||||||||||||
5/23/05 18:02 | 5/18/05 | NERX | Neorx Corp | WA | Health | Diagn | In Vitro & In Vivo Diagnostic | Stevens David R | WA | D | P | 18 | 0.5110 | 0 | 35 | New | 35 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |